Maintenance of mucosal homeostasis by commensal Th17 cells
共生 Th17 细胞维持粘膜稳态
基本信息
- 批准号:10621283
- 负责人:
- 金额:$ 56.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-06 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAnti-Inflammatory AgentsAntigen PresentationAntigensAutomobile DrivingBacteriaCD4 Positive T LymphocytesCarrier ProteinsCell physiologyCellsComplexDataDevelopmentDiseaseEndocytosisEpithelial CellsEpitheliumExocytosisFosteringGenerationsHealthHomeostasisHumanImmuneImmune systemImmunologyIn VitroInflammationInflammatoryInterleukin-10IntestinesInvestigationMaintenanceMicrobeMucosal Immune ResponsesMucosal ImmunityMucous MembraneMusNaturePathway interactionsPeptidesPhenotypePlayProcessReactionRegulationRoleSamplingSideSterilitySymbiosisT cell responseT-LymphocyteTestingTissuesantigen processingcommensal microbescytokineexperimental studyfactor Cgut inflammationimmunoreactionin vivoinsightintestinal epitheliumintestinal homeostasismicrobialmucosal sitemucosal vaccinenovelpathogenpreventprogramsreceptorresponsesensortranscription factortranscytosis
项目摘要
Mucosa are sites of conventional immune system attack for defense against invasive pathogens. Mucosa
were also once regarded simply as inert barriers preventing commensal microbes from accessing sterile
tissues. Instead, emerging evidence suggests a complex interplay between commensal microbes, barrier
epithelial cells, and the immune system that is essential for local and systemic homeostasis of the host.
We have recently provided insight into how recognition of commensal components by epithelial and innate
immune cells triggers a specific immune reaction and why the nature of this reaction could foster host-
microbe symbiosis instead of outright microbial rejection. Specifically, we showed that antigen acquisition
be intestinal epithelial cells (IECs) of commensal antigens drives a non-pathogenic commensal Th17 cell
response. Here we propose to mechanistically examine the fate of intracellular IEC antigens and the role
of IECs in the process, as well as the phenotype and function of the generated Th17 cells. We will address
these mechanism by pursuing two specific aims to explore 1) Role of IECs in priming of commensal T cell
responses and 2) Generation and function of anti-inflammatory commensal Th17 cells. Our studies
address fundamental mechanisms of mucosal immunity to commensal microbes and if successful will
provide novel mechanisms of IEC function, as well as pathways for generation of protective mucosal T cell
responses.
粘膜是常规免疫系统攻击防御入侵病原体的部位。粘膜
也曾被简单地认为是阻止微生物进入无菌环境的惰性屏障
组织中相反,新出现的证据表明,肠道微生物、屏障
上皮细胞,以及对宿主的局部和全身稳态必不可少的免疫系统。
我们最近提供了深入了解如何识别的上皮和先天性成分,
免疫细胞触发特定的免疫反应,为什么这种反应的性质可以促进宿主-
微生物共生而不是完全的微生物排斥。具体来说,我们发现抗原获得
肠道抗原的肠上皮细胞(IEC)驱动非致病性肠道Th 17细胞
反应在这里,我们建议从机制上研究细胞内IEC抗原的命运和作用,
的IEC的过程中,以及所产生的Th 17细胞的表型和功能。我们将解决
本研究通过两个具体的目的来探讨这些机制:1)IEC在外周血T细胞启动中的作用
2)抗炎性骨髓Th 17细胞的产生和功能。我们的研究
解决粘膜免疫对肠道微生物的基本机制,如果成功,
提供IEC功能的新机制,以及产生保护性粘膜T细胞的途径
应答
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ivaylo Ivanov Ivanov其他文献
Ivaylo Ivanov Ivanov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ivaylo Ivanov Ivanov', 18)}}的其他基金
Maintenance of mucosal homeostasis by commensal Th17 cells
共生 Th17 细胞维持粘膜稳态
- 批准号:
10282976 - 财政年份:2021
- 资助金额:
$ 56.7万 - 项目类别:
Maintenance of mucosal homeostasis by commensal Th17 cells
共生 Th17 细胞维持粘膜稳态
- 批准号:
10462753 - 财政年份:2021
- 资助金额:
$ 56.7万 - 项目类别:
Non-redundant functions of type 3 innate lymphoid cells in mucosal immunity
3型先天淋巴细胞在粘膜免疫中的非冗余功能
- 批准号:
9902326 - 财政年份:2019
- 资助金额:
$ 56.7万 - 项目类别:
Discovery of immunomodulatory gut microbes with MAGIC
利用 MAGIC 发现免疫调节肠道微生物
- 批准号:
9808632 - 财政年份:2019
- 资助金额:
$ 56.7万 - 项目类别:
Non-redundant functions of type 3 innate lymphoid cells in mucosal immunity
3型先天淋巴细胞在粘膜免疫中的非冗余功能
- 批准号:
10374839 - 财政年份:2019
- 资助金额:
$ 56.7万 - 项目类别:
New mechanism of commensal bacteria interaction with host immunity
共生菌与宿主免疫相互作用的新机制
- 批准号:
9317868 - 财政年份:2017
- 资助金额:
$ 56.7万 - 项目类别:
Mechanisms of Mucosal Th17 Cell Induction By Segmented Filamentous Bacteria
分节丝状细菌诱导粘膜 Th17 细胞的机制
- 批准号:
8819130 - 财政年份:2013
- 资助金额:
$ 56.7万 - 项目类别:
Mechanisms of Mucosal Th17 Cell Induction By Segmented Filamentous Bacteria
分节丝状细菌诱导粘膜 Th17 细胞的机制
- 批准号:
10475627 - 财政年份:2013
- 资助金额:
$ 56.7万 - 项目类别:
Mechanisms of Mucosal Th17 Cell Induction By Segmented Filamentous Bacteria
分节丝状细菌诱导粘膜 Th17 细胞的机制
- 批准号:
8650824 - 财政年份:2013
- 资助金额:
$ 56.7万 - 项目类别:
Mechanisms of Mucosal Th17 Cell Induction By Segmented Filamentous Bacteria
分节丝状细菌诱导粘膜 Th17 细胞的机制
- 批准号:
9244017 - 财政年份:2013
- 资助金额:
$ 56.7万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 56.7万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 56.7万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 56.7万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 56.7万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 56.7万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 56.7万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 56.7万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 56.7万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 56.7万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 56.7万 - 项目类别:














{{item.name}}会员




